Real life experience with omalizumab in patients with poorly controlled moderate to severe asthma

被引：0
|
作者：
Ricciardi, L. [1 ]
Arena, E. [1 ]
Loschiavo, G. [1 ]
D'Angelo, A. G. [1 ]
Sinagra, F. [1 ]
Paffumi, I [1 ]
Saitta, S. [1 ]
Marotta, G. [1 ]
机构：
[1] Univ Hosp, Allergy & Clin Immunol Unit, Messina, Italy
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [31] Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience
    Jain, Salina
    Saralaya, Dinesh
    Regan, Karen
    Walker, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [32] Omalizumab for severe chronic spontaneous urticaria (CSU)-real life experience of 251 patients
    Vadasz, Z.
    Asher, I
    Tal, Y.
    Rotem, M.
    Shichter-Confino, V
    Greif, Y.
    Kessel, A.
    Agmon-Levin, N.
    Benor, S.
    Lachover-Roth, I
    Zeldin, Y.
    Stein, M.
    Toker, O.
    Mahlab-Guri, K.
    Bezalel-Rosenberg, S.
    Hassoun, J.
    Toubi, E.
    Sthoeger, Z.
    ALLERGY, 2017, 72 : 716 - 716
  • [33] Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
    Pelaia, Corrado
    Crimi, Claudia
    Nolasco, Santi
    Carpagnano, Giovanna Elisiana
    Brancaccio, Raffaele
    Buonamico, Enrico
    Campisi, Raffaele
    Gagliani, Claudia
    Patella, Vincenzo
    Pelaia, Girolamo
    Valenti, Giuseppe
    Crimi, Nunzio
    BIOMEDICINES, 2021, 9 (12)
  • [34] Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
    M. Caminati
    G. Senna
    G. Stefanizzi
    R. Bellamoli
    S. Longhi
    F. Chieco-Bianchi
    G. Guarnieri
    S. Tognella
    M. Olivieri
    C. Micheletto
    G. Festi
    E. Bertocco
    M. Mazza
    A. Rossi
    A. Vianello
    BMC Pulmonary Medicine, 16
  • [35] European Real-Life Experience Of Omalizumab (Xolair) And Maintenance Oral Corticosteroid Use In Patients With Severe Persistent Allergic Asthma
    Molimard, M.
    Niven, R.
    Buhl, R.
    Le Gros, V.
    Thielens, A.
    Thirl-well, J.
    Panahloo, Z.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S156 - S156
  • [36] Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
    Caminati, M.
    Senna, G.
    Stefanizzi, G.
    Bellamoli, R.
    Longhi, S.
    Chieco-Bianchi, F.
    Guarnieri, G.
    Tognella, S.
    Olivieri, M.
    Micheletto, C.
    Festi, G.
    Bertocco, E.
    Mazza, M.
    Rossi, A.
    Vianello, A.
    BMC PULMONARY MEDICINE, 2016, 16
  • [37] Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
    Kralimarkova, Tanya
    Staevska, Maria
    Lazarova, Tsvetelina
    Hristova, Diana
    Dimitrov, Vasil
    Popov, Todor
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [38] "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
    Brusselle, G.
    Michils, A.
    Louis, R.
    Dupont, L.
    de Maele, B. Van
    Delobbe, A.
    Pilette, C.
    Lee, C. S.
    Gurdain, S.
    Vancayzeele, S.
    Lecomte, P.
    Hermans, C.
    MacDonald, K.
    Song, M.
    Abraham, I.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1633 - 1642
  • [39] Predictors of response to therapy with omalizumab in patients with severe allergic asthma-a real life study
    Kallieri, Maria
    Papaioannou, Andriana
    Papathanasiou, Evgenia
    Dontsi, Polyxeni
    Papiris, Spyridon
    Loukides, Stelios
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [40] Predictors Of Asthma Exacerbation Among Patients With Poorly Controlled Moderate Persistent Asthma
    Quezada, W. A.
    Dimango, E. A.
    Kwak, E.
    Reibman, J.
    Rogers, L.
    Wei, C. Y.
    Holbrook, J. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345